BioForce Nanosciences Holdings is an early-stage nutritional supplement company with a single product: BioForce Eclipse, a private-label multivitamin and mineral powder supplement containing amino acids, vitamins, and plant-based proteins. The product targets athletes, fitness enthusiasts, and older adults. BioForce does not manufacture Eclipse — instead, it private-labels the product through a third-party supplier, Body Align, which owns the underlying formula. BioForce sells, or intends to sell, through its own website and via B2B outreach to gyms, health food stores, sporting goods stores, supermarkets, and pharmacies. The company operates on consignment terms, meaning it only pays for product upon sale, which limits upfront inventory costs but reflects limited supplier leverage. As of the most recent filing, BioForce had no customers in either FY2022 or FY2023. The company has three full-time employees and operates out of a single office in Virginia Beach. BioForce also has a wholly-owned subsidiary, Element Global, formed to pursue acquisitions in media, entertainment, and sports, though no transaction has been completed. BioForce's stated growth strategy involves social media marketing, direct outreach to retail and gym channels, and eventually TV and radio advertising.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →